Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block Efficacy in Lower Abdominal OncoSurgeries
NCT03165383Completed
- Sponsor
- Rajiv Gandhi Cancer Institute and Research Centre
- Start
- Feb 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Rajiv Gandhi Cancer Institute and Research Centre. Primary endpoint: Visual Analogue Pain Score at 24 hours. Started Feb 2013; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03165383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03165383.